Pyrazinamide

Pyrazinamide

SCHEMBL24102

NC(=O)c1cnccn1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

fasrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmB1rpmB2rpmCrpmDrpmErpmFrpmG1rpmG2rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsR1rpsR2rpsSrpsTrpsZ

The experimentally established mechanism targets of Pyrazinamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrazinamide SCHEMBL18364991 1.00 — —
Pyrazinamide SCHEMBL29518620 1.00 — —
Pyrazinamide SCHEMBL29408106 1.00 — —
Pyrazinamide SCHEMBL18364990 1.00 — —
Pyrazinamide SCHEMBL2433265 1.00 ADORA3 (1.00) —
Pyrazinamide SCHEMBL18364989 1.00 — —
Pyrazinamide SCHEMBL6162016 0.98 ADORA3 (0.95) —
Pyrazinamide SCHEMBL31514254 0.98 ADORA3 (0.95) —
Pyrazinamide SCHEMBL11617895 0.98 ADORA3 (0.95) —
Pyrazinamide SCHEMBL5010455 0.98 ADORA3 (0.95) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 28776 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122091700-A Lithium ion battery and power utilization device — 2026-05-26 — — CN claimed
CN-117045657-B Pharmaceutical composition and application thereof Guangzhou Jiayue Pharmaceutical Technology Co.,Ltd. (CN) 2026-05-26 — — CN claimed
US-20260137766-A1 LIPOSOME FORMULATIONS FOR TREATMENT OF ACTIVE TUBERCULOSIS ARCHIVEL FARMA S L (ES) 2026-05-21 — — US claimed
EP-4736841-A1 A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT IQ medical GmbH (DE) 2026-05-06 — — EP claimed
US-12616691-B2 Use of fatty acid oxidation inhibitors as antimicrobials WASHINGTON UNIVERSITY IN ST. LOUIS (US) 2026-05-05 — — US claimed
US-20260108619-A1 CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2026-04-23 — — US claimed
EP-4727950-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS GlaxoSmithKline Intellectual Property Development Ltd (GB) 2026-04-22 — — EP claimed
EP-4531856-B1 BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION ALK ABELLO AS (DK) 2026-04-22 — — EP claimed
EP-4729525-A1 NEWLY SYNTHESIZED BORON-NITROGEN HETEROCYCLES AND THEIR CONJUGATES WITH PHARMACEUTICALLY UTILIZABLE SUBSTANCES Julius-Maximilians-Universität Würzburg (DE) 2026-04-22 — — EP claimed
EP-4723893-A2 COMPOSITIONS AND METHODS TO MITIGATE PHYTOTOXIC EFFECTS OF AGRICHEMICALS Ascribe Bioscience Inc. (US) 2026-04-15 — — EP claimed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 — — WO claimed
WO-1991005771-A1 LIPOPHILIC ACYLPYRAZINAMIDE PRODRUGS SCHREIER HANS (US) 1991-05-02 — — WO claimed
EP-0305008-A2 Tumor or cancer cell killing therapy and agents useful therefor OXI-GENE, INC. (US) 1989-03-01 — — EP claimed
CN-85102070-B Transfer printing paper and transfer printing of textile material 西柏地产有限公司 1988-11-30 — — CN claimed
CN-85102070-A The transfer printing paper of textile material and transfer printing — 1987-01-24 — — CN claimed
US-4406755-A Bright palladium electrodeposition TECHNIC INC. (US) 1983-09-27 — — US claimed
US-4167392-A Transfer printing process for hydrophilic fibrous material or blends of hydrophilic and synthetic fibrous material, with reactive disperse dyes CIBA-GEIGY AG (CH) 1979-09-11 — — US claimed
US-4110237-A Compositions containing a diazine and a halogen compound for catalyzing copper etching solutions Tokai Denka Kabushiki Kaisha (JP) 1978-08-29 — — US claimed
US-4093415-A DYEING, OPTICAL BRIGHTENERS, CARRIERS CIBA GEIGY AG (CH) 1978-06-06 — — US claimed
US-3936332-A DIAZINE, PEROXYSULFATE, HALOGEN COMPOUND TOKAI DENKA KOGYO KABUSHIKI KAISHA (JA) 1976-02-03 — — US claimed
Send feedback